default author photo

Xiaoqiang Wu

Zhengzhou University - Department of Urology

Zhengzhou, 450003

China

  • Zhengzhou University - Department of Urology

SCHOLARLY PAPERS

2

DOWNLOADS

185

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Role of Immune Checkpoint Inhibitor-Based Therapies for Metastatic Renal Cell Carcinoma in the First-Line Setting: A Systematic Review and Bayesian Network Analysis

Number of pages: 36 Posted: 18 Jun 2019
Junpeng Wang, Xin Li, Xiaoqiang Wu, Zhiwei Wang, Chan Zhang, Guanghui Cao, Xiaofan Zhang, Feng Peng and Tianzhong Yan
Zhengzhou University, Zhengzhou University, Zhengzhou University - Department of Urology, Zhengzhou University, Zhengzhou University - Department of Urology, Zhengzhou University - Department of Urology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology and Zhengzhou University - Department of Urology
Downloads 135 (544,251)

Abstract:

Loading...

renal cell carcinoma; first-line systemic therapies; immune checkpoint inhibitor; efficacy; safety

2.

First-Line Systemic Treatments for Advanced/Metastatic Renal Cell Carcinoma of Favorable-, Intermediate-, and Poor-Risk, Respectively: A Bayesian Network Analysis

Number of pages: 36 Posted: 28 Jan 2019
Junpeng Wang, Xin Li, Zhiwei Wang, Jianhua Hou, Lei Yang, Peiyan Zhao, Zhenya Li, Xiaoqiang Wu and Tianzhong Yan
Zhengzhou University, Zhengzhou University, Zhengzhou University, Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Zhengzhou University - Zhengzhou Central Hospital, Zhengzhou University - Department of Urology and Zhengzhou University - Department of Urology
Downloads 50 (1,063,489)
Citation 1

Abstract:

Loading...

renal cell carcinoma; systemic therapy; risk stratification; efficacy; safety